Literature DB >> 28433114

Hepatic features of Wilson disease.

Salih Boga1, Aftab Ala2, Michael L Schilsky3.   

Abstract

In Wilson disease (WD) defective AT7B function leads to biliary copper excretion and pathologic copper accumulation, particularly in liver and brain, where it induces cellular damage. Liver disease most often precedes neurologic or psychiatric manifestations. In most patients with neurologic or psychiatric symptoms there is some degree of liver disease at the time of disease presentation. Hepatic manifestations of WD can be extremely variable. Patients with clinically asymptomatic WD are often found by family screening or identified on routine laboratory testing. Others may have a clinical picture of chronic active hepatitis or of end-stage liver disease with cirrhosis. A minority present with acute liver failure, often on the background of advanced fibrosis. Complications from liver disease may be related to portal hypertension and concomitant liver disease may accelerate the course of liver disease. Liver cancer may occur in patients with WD, most commonly when cirrhosis and inflammation are present. The prognosis of patients with WD is excellent, especially for those without cirrhosis at the time of diagnosis, but requires timely initiation of appropriate therapy specific for WD and for the patient's liver disease independent of WD.
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Wilson disease; copper; liver disease; liver failure

Mesh:

Substances:

Year:  2017        PMID: 28433114     DOI: 10.1016/B978-0-444-63625-6.00009-4

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  10 in total

Review 1.  Clinical presentations of Wilson disease.

Authors:  Samuel Shribman; Thomas T Warner; James S Dooley
Journal:  Ann Transl Med       Date:  2019-04

Review 2.  Challenges in the diagnosis of Wilson disease.

Authors:  Aurélia Poujois; France Woimant
Journal:  Ann Transl Med       Date:  2019-04

3.  Presentations of Wilson Disease.

Authors:  Michael Schilsky
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-11

Review 4.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

5.  Next-generation sequencing: a decisive diagnostic aid for atypical Wilson's disease.

Authors:  Aurelia Poujois; Mathilde Renaud; Amory Jardel; Céline Bonnet; Solène Frismand-Kryloff; Jean Marie Ravel; Emmanuelle Schmitt; Mickael Alexandre Obadia; Sébastien Delassaux; Myriam Bronner
Journal:  J Neurol       Date:  2022-07-21       Impact factor: 6.682

6.  DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease.

Authors:  Navasona Krishnan; Christy Felice; Keith Rivera; Darryl J Pappin; Nicholas K Tonks
Journal:  Genes Dev       Date:  2018-06-26       Impact factor: 12.890

7.  Cirrhosis in Wilson Disease is characterized by Impaired Hepatic Synthesis, Leukopenia and Thrombocytopenia.

Authors:  Hao-Jie Zhong; Ping Xiao; Da Lin; Hui-Min Zhou; Xing-Xiang He
Journal:  Int J Med Sci       Date:  2020-05-29       Impact factor: 3.738

8.  Dysregulated Choline, Methionine, and Aromatic Amino Acid Metabolism in Patients with Wilson Disease: Exploratory Metabolomic Profiling and Implications for Hepatic and Neurologic Phenotypes.

Authors:  Tagreed A Mazi; Gaurav V Sarode; Anna Czlonkowska; Tomasz Litwin; Kyoungmi Kim; Noreene M Shibata; Valentina Medici
Journal:  Int J Mol Sci       Date:  2019-11-26       Impact factor: 5.923

9.  Liver cirrhosis prediction for patients with Wilson disease based on machine learning: a case-control study from southwest China.

Authors:  Ke Chen; Yang Wan; Ju Mao; Yuqing Lai; Gesang Zhuo-Ma; Peiwei Hong
Journal:  Eur J Gastroenterol Hepatol       Date:  2022-07-25       Impact factor: 2.586

10.  Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis.

Authors:  Hao-Jie Zhong; Huan-Huan Sun; Lan-Feng Xue; Eileen M McGowan; Yu Chen
Journal:  World J Gastroenterol       Date:  2019-01-21       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.